Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer

Abstract Background The types of outcomes measured collected in clinical studies and those required for cost-effectiveness analysis often differ. Decision makers routinely use quality adjusted life years (QALYs) to compare the benefits and costs of treatments across different diseases and treatments...

Full description

Bibliographic Details
Main Authors: Laura A. Gray, Monica Hernandez Alava, Allan J. Wailoo
Format: Article
Language:English
Published: BMC 2021-11-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-021-08964-5